Urgent

New-onset atrial fibrillation - ED pathway

Acute AF management · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

New atrial fibrillation in the ED: stabilise, hunt for a precipitant, then choose rate or rhythm control and decide on anticoagulation. Haemodynamic instability mandates immediate cardioversion.

Assessment

Investigations

  • ECG; assess haemodynamic stability and onset time (<48 h?)
  • Identify precipitants: sepsis, PE, thyrotoxicosis, electrolytes, alcohol, ischaemia
  • Bloods including TFTs, electrolytes; CHA2DS2-VASc and bleeding risk

Management

  • Unstable (shock, ischaemia, syncope, heart failure): synchronised DC cardioversion
  • Treat any precipitant (often the AF then settles)
  • Rate control first-line for most: beta-blocker or diltiazem (digoxin if heart failure/hypotension)
  • Rhythm control (flecainide if no structural heart disease, or amiodarone) if <48 h onset or anticoagulated/TOE-guided
  • Anticoagulate based on CHA2DS2-VASc (and assess bleeding risk) - do not cardiovert >48 h or unknown onset without anticoagulation/TOE
  • Admit or discharge with cardiology/arrhythmia follow-up per response
  • Avoid AV-nodal blockers in pre-excited AF (WPW)

Drugs & doses

Beta-blocker or diltiazem (rate control)
Flecainide / amiodarone (rhythm control)
DC cardioversion (if unstable)
Anticoagulation per CHA2DS2-VASc

Disposition

Per response; cardiology follow-up.

Cardiovert unstable AF immediately, but for stable AF treat the precipitant, rate-control, and never cardiovert AF >48 h without anticoagulation or a TOE.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.